title: [Cases of lethal midline granuloma (polymorphic reticulosis) at our department in a recent 10-year period].
abstract: We had 18 patients (15 males and 3 females) with lethal midline granuloma (polymorphic reticulosis) in the period from 1981 to 1990. This number was about 5.6% of the total number of patients with malignant head and neck tumors that we encountered during this period. An average of 9.1 months separated the first appearance of disease and the beginning of treatment. Most of the 18 patients underwent both radiation therapy and chemotherapy (COP, CHOP, MACOP-B), but, since their disease had reached an advanced stage, 3 underwent radiation therapy only, 3 underwent chemotherapy only, and 1 received no radical therapy at all. Of the 18 patients, 13 died of the disease. In of 6 of these, the disease was confined to the local lesion. The 5-year cumulative survival rate was 15.7% (Kaplan-Meier). Fourteen autopsy studies revealed that tumor cells had invaded the liver (92.8%), lung (92.8%) and spleen (71.4%) and in all cases it was in leukemic patterns. Fifteen cases were studied for tumor surface marker phenotype, but none was found to be positive for L26, CD43, Leu M1 (CD15), or MAC 387. Five cases were positive for UCHL-1 (CD45RO) and 10 cases were positive for lysozyme. All cases were positive for Ki-1 (CD30).
authors.affiliation: Department of Otolaryngology, Osaka Prefectural General Hospital.
authors.forename: C
authors.initials: C
authors.lastname: Hatta
authors.forename: M
authors.initials: M
authors.lastname: Ishida
authors.forename: T
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Y
authors.initials: Y
authors.lastname: Sugiyama
authors.forename: N
authors.initials: N
authors.lastname: Makino
authors.forename: K
authors.initials: K
authors.lastname: Kotoh
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D005260:Female; D006103:Granuloma, Lethal Midline / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D008206:Lymphatic Diseases / Q000378:metabolism / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009669:Nose Neoplasms / Q000378:metabolism / Q000628:therapy; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor